Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

OBJECTIVE: To compare ultra-long-acting insulin degludec with glargine for efficacy and safety in insulin-naive patients with type 2 diabetes inadequately controlled with oral antidiabetic drugs (OADs). RESEARCH DESIGN AND METHODS: In this 1-year, parallel-group, randomized, open-label, treat-to-tar...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Zinman, Bernard, Philis-Tsimikas, Athena, Cariou, Bertrand, Handelsman, Yehuda, Rodbard, Helena W., Johansen, Thue, Endahl, Lars, Mathieu, Chantal
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2012
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3507614/
https://ncbi.nlm.nih.gov/pubmed/23043166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-1205
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki